CHARACTERIZATION OF GDNF ALPHA 1 (GFR ALPHA 1) RECEPTOR
CHARACTERIZATION OF GDNF ALPHA 1 (GFR ALPHA 1) RECEPTOR
批准号:
6103922
负责人:
BARRY J. HOFFER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
胶质细胞源性神经营养因子
拯救运动神经元和黑质多巴胺能(DA)细胞,
在不同种类的动物中诱导细胞死亡。此外,本发明还提供了一种方法,
GDNF导致行为功能的显着改善
帕金森病猴子的研究GDNF的高亲和力受体具有
已被克隆(GFR α 1),其表达模式表明
它并不局限于包含运动神经元的大脑区域
和DA能细胞,这表明GDNF可能激活几个
细胞的子类型。确定GFR α 1的表型
表达细胞,我们使用了解剖技术的组合,
并发现GFR α 1在特定人群中表达,
细胞正如预期的那样,我们发现GFR α 1表达于
黑质多巴胺能细胞(SNC)和黑质多巴胺能细胞(DCs)的分布,
腹侧被盖区此外,GFR α 1表达于
GABA能细胞位于外侧SNC或
网状黑质(SNR)。这些GABA能细胞
在SNR的尾侧水平丰富。我们的结果表明
GDNF诱导的偏侧帕金森病患者行为的改善
动物模型也可能通过GDNF的作用介导,
SNR中的GABA能细胞。我们将用一只半帕金森大鼠
和一个小鼠模型来验证这个假设。 在海马体内
GFR α 1表达细胞是多巴胺能的,
(下托、锥体和颗粒细胞)或GABA能
(interneurons)。多巴胺能海马下托神经元构成了一个神经系统,
主要的兴奋性输入到延髓核(NAcc),表明
GDNF对表达GFR α 1的海马下托细胞的作用
可能导致位于Nacc的细胞的调节。我们提出
来研究这些细胞的性质。我们发现海马
表达GFR α 1的GABA能细胞含有Ca 2+结合蛋白,
小清蛋白(PV)。此外,大多数海马
含有PV的神经元表达GFR α 1。作为PV中间神经元
是神经生长因子(NGF)的主要来源。
海马(71%的NGF阳性细胞含有PV),我们将
研究GDNF通过其GFR α 1在多大程度上
调节含PV细胞中NGF的表达。 发表
结果显示GDNF-(GDNF-/-)或GFR α 1-
(GFRa-1-/-)缺陷小鼠缺乏肾脏,出生后一天死亡。
相比之下,这些突变小鼠的大脑看起来正常。因此
认为GDNF及其受体对于肿瘤的发生和发展是重要的,
发展和/或生存的肾脏系统,他们不是
对中枢神经系统的神经元至关重要。我们的数据表明GFR α
1在出生后可能成熟的一些细胞中表达,因此,
我们将研究这些细胞的发育和/或存活
特定类型的细胞在新生GDNF(-/-)中受损,
GFR α 1(-/-)纯合子小鼠,以及相应的成年小鼠
杂合子 使用脑缺血模型(中
大脑动脉,结扎)或物理皮质损伤,我们发现,
颗粒细胞中GFR α 1表达的稳健上调
与接受损伤的区域同侧。在这两种模型中,GFR
α 1上调在缺血或物理损伤后6小时达到峰值,
损伤这些结果表明,GFR α 1可能是
内源性神经保护系统,这是激活后
脑损伤,并可能作为大脑中的防御机制。我们将
研究可能参与这种防御的大脑回路
机制,我们将评估是否观察到类似情况
在甲基苯丙胺引起的脑损伤中
英文摘要
Glial cell line-derived neurotrophic factor (GDNF)
rescues motoneurons and nigral dopaminergic (DA) cells from
induced cell death in different species of animals. In addition,
GDNF results in a remarkable improvement of behavioral functions
in Parkinsonian monkeys. A high affinity receptor for GDNF has
been cloned (GFR alpha 1), whose pattern of expression indicates
that it is not restricted to those brain areas containing motoneurons
and DAergic cells, suggesting that GDNF might activate several
sub-types of cells. To identify the phenotype of GFR alpha 1
expressing cells, we used a combination of anatomical techniques
and found that GFR alpha 1 is expressed in defined populations of
cells. As expected, we found that GFR alpha 1 is expressed in
DAergic cells of the substantia nigra compacta (SNC) and the
ventral tegmental area. In addition, GFR alpha 1 is expressed in
GABAergic cells located either in the lateral SNC or in the
substantia nigra reticulata (SNR). These GABAergic cells are more
abundant in the caudal levels of the SNR. Our results suggest that
GDNF-induced improvements in the behavior of hemi-parkinsonian
animal models might be also mediated by GDNF actions on
GABAergic cells in the SNR. We will use a hemi-parkisonian rat
and a mouse model to test this hypothesis. Within the hippocampal
formation, GFR alpha 1 expressing cells are either glutaminergic
(subicular, pyramidal and granule cells) or GABAergic
(interneurons). The glutaminergic subicular neurons constitute a
major excitatory input to the nucleus accumbens(NAcc), suggesting
that actions of GDNF on subicular GFR alpha 1 expressing cells
might result in regulation of cells located in the Nacc. We propose
to investigate the nature of these cells. We found that hippocampal
GABAergic cells expressing GFR alpha 1 contain the Ca2+-binding
protein parvalbumin (PV). Furthermore, most of the hippocampal
neurons that contain PV express GFR alpha 1. As PV interneurons
are the main source of nerve growth factor (NGF) in the
hippocampus (71% of NGF positive cells contain PV), we will
investigate to what extent GDNF, via its GFR alpha 1 might
regulate the expression of NGF in PV containing cells. Published
results show that either GDNF- (GDNF-/-) or GFR alpha 1-
(GFRa-1-/-) deficient mice lack kidneys and die one day after birth.
In contrast, the brains of these mutant mice appear normal. Thus, it
is believed that while GDNF and its receptor are important for the
development and/or survival for the renal system, they are not
essential for neurons of the CNS. Our data suggest that GFR alpha
1 is expressed in some cells that might mature after birth, therefore,
we will investigate if the development and/or survival of these
particular type of cells is compromised in newborn GDNF (-/-) and
GFR alpha 1 (-/-) homozygous mice, and in the corresponding adult
heterozygous. Using either a cerebral ischemia model (middle
cerebral artery, ligation) or physical cortical injury, we found a
robust up-regulation of GFR alpha 1 expression in granule cells
ipsilateral to the area receiving the insult. In both models, GFR
alpha 1 up-regulation peaks 6 hours following ischemia or physical
injury. These results indicate that GFR alpha 1 might be part of an
endogenous neuroprotective system, that is activated following a
brain insult and may act as defense mechanism in the brain. We will
investigate the possible brain circuitry involved in this defense
mechanism and we will evaluate if a similar situation is observed
during methamphetamine-induced brain injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6311452
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2000
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6097978
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6267219
-
项目类别:
-
资助金额:$14.19万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FUNCTION OF CNS NEURAL GRAFTS
-
批准号:6112032
-
项目类别:
-
资助金额:$12.74万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FETAL TISSUE TRANSPLANT AND OTHER GENE EXPRESSION SYSTEMS
-
批准号:6111440
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:BARRY J. HOFFER
-
依托单位:
FETAL TISSUE TRANSPLANT AND OTHER GENE EXPRESSION SYSTEMS
-
批准号:6243058
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
FUNCTION OF CNS NEURAL GRAFTS
-
批准号:6243412
-
项目类别:
-
资助金额:$12.28万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL CORRELATES OF AGING IN BRAIN CELL GRAFTS
-
批准号:6233990
-
项目类别:
-
资助金额:$13.8万
-
财政年份:1997
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMER'S DISEASE
-
批准号:3090877
-
项目类别:
-
资助金额:$9.47万
-
财政年份:1992
-
负责人:BARRY J. HOFFER
-
依托单位:
COMPLEX I IN PARKINSONS DISEASE
-
批准号:3415971
-
项目类别:
-
资助金额:$21.77万
-
财政年份:1991
-
负责人:BARRY J. HOFFER
-
依托单位:
REGULATING CEREBROSPINAL FLUID FORMATION
-
批准号:2266303
-
项目类别:
-
资助金额:$14.34万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554695
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554697
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
SCIENTIFIC EVALUATION AND PLANNING
-
批准号:3554696
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1990
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090882
-
项目类别:
-
资助金额:$47.79万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090878
-
项目类别:
-
资助金额:$33.14万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMERS DISEASE
-
批准号:2048871
-
项目类别:
-
资助金额:$87.28万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090879
-
项目类别:
-
资助金额:$35.31万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
AMINERGIC FUNCTION IN AGING AND ALZHEIMERS DISEASE
-
批准号:3090883
-
项目类别:
-
资助金额:$73.55万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
PHARMACOLOGICAL SUBSTRATES IN AGING
-
批准号:3090881
-
项目类别:
-
资助金额:$53.53万
-
财政年份:1984
-
负责人:BARRY J. HOFFER
-
依托单位:
海外基金